Hepatitis Monthly

Published by: Kowsar

Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/ AIDS Patients: A Randomized Controlled Trial

Babak Sayad 1 , * , Seyyed Moayed Alavian 2 , Farid Najafi 3 , Bita Soltani 1 , Maria Shirvani 1 , Alireza Janbakhsh 1 , Feyzollah Mansouri 1 , Mandana Afsharian 1 , Siavash Vaziri 1 , Arash Alikhani 1 and Homayoon Bashiri 1
Authors Information
1 Liver Disease and Hepatitis Research Center, Kermanshah University of Medical Sciences, babaksayad@yahoo.com, IR Iran
2 Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, IR Iran
3 Health Research Center, Kermanshah University of Medical Sciences, IR Iran
Article information
  • Hepatitis Monthly: , 12 (9); 6234
  • Published Online: September 30, 2012
  • Article Type: Research Article
  • Received: May 9, 2012
  • Accepted: June 13, 2012
  • DOI: 10.5812/hepatmon.6234

To Cite: Sayad B, Moayed Alavian S, Najafi F, Soltani B, Shirvani M, et al. Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/ AIDS Patients: A Randomized Controlled Trial, Hepat Mon. Online ahead of Print ;12(9):6234. doi: 10.5812/hepatmon.6234.

Abstract
© 2012, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments